• Users Online: 127
  • Print this page
  • Email this page
Year : 2019  |  Volume : 8  |  Issue : 1  |  Page : 16-23

Biochemical and serological characterisation of beta-haemolytic streptococci from various clinical samples in a tertiary care hospital, South India

1 Department of Microbiology, Sri Venkateswaran Institute of Medical Sciences, Tirupathi, Andhra Pradesh, India
2 Department of Medicine, Sri Venkateswaran Institute of Medical Sciences, Tirupathi, Andhra Pradesh, India

Correspondence Address:
R Jayaprada
Associate Professor, Department of Microbiology, Sri Venkateswaran Institute of Medical Sciences, Tirupati, Andhra Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JCSR.JCSR_39_19

Rights and Permissions

Introduction: Beta-haemolytic streptococci (BHS) are one of the most frequent human pathogens capable of producing a variety of diseases ranging from pharyngitis, impetigo, to more severe and life-threatening diseases such as toxic shock syndrome, neonatal sepsis, pneumonia, meningitis and acute rheumatic fever. Methods: This was a hospital-based prospective study which was carried out on BHS isolated from various clinical specimens submitted in microbiology laboratory from inpatients and outpatients, and these isolates were studied biochemically by pyrrolidonyl arylamidase (PYR), hippurate hydrolysis and sugar fermentation tests. Differentiation of various serogroups was done with bacitracin (0.04 U), co-trimoxazole (sulphamethoxazole-trimethoprim [23.75/1.25 mcg]) and penicillin (10 units/disc) discs (n = 220). The isolates were identified serologically by Hi Strep™ Latex agglutination test Kit (Himedia). Results: The findings showed that the highest percentage of streptococci isolated was from throat swabs (35.5%), followed by sputum (15.9%), urine (14.1%), blood (10.5%), pus (8.6%), cerebrospinal fluid (6.4%), bronchoalveolar lavage (5.9%) and endotracheal tips (3.2%). The highest percentage of BHS belongs to Group C (74, 33.6%), followed by Group G (51, 23.2%), Group B (42, 19.1%), Group F (28, 12.7%), Group A (21, 9.5%) and Group D (4, 1.8%). Conclusions: Rapid identification and consequent prompt treatment of patients with BHS can reduce the risk of spread and aid in the prevention of infections and their serious complications, such as rheumatic fever/rheumatic heart disease, nephritis and local or systemic infections.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded72    
    Comments [Add]    
    Cited by others 1    

Recommend this journal